Corient Private Wealth LP Invests $14.42 Million in Ventas, Inc. $VTR

Corient Private Wealth LP acquired a new position in shares of Ventas, Inc. (NYSE:VTR) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 162,336 shares of the real estate investment trust’s stock, valued at approximately $14,416,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of VTR. NewEdge Advisors LLC increased its position in shares of Ventas by 856.1% during the first quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock valued at $545,000 after acquiring an additional 7,097 shares during the last quarter. Empowered Funds LLC raised its stake in shares of Ventas by 6.8% in the 1st quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after acquiring an additional 536 shares during the period. Woodline Partners LP lifted its holdings in shares of Ventas by 46.8% in the 1st quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock worth $2,532,000 after acquiring an additional 11,739 shares during the last quarter. Focus Partners Wealth lifted its holdings in shares of Ventas by 130.4% in the 1st quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock worth $1,486,000 after acquiring an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL purchased a new position in shares of Ventas during the 2nd quarter worth approximately $805,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Ventas Trading Down 1.2%

Shares of VTR stock opened at $91.78 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. The stock has a market capitalization of $47.08 billion, a P/E ratio of 169.96, a price-to-earnings-growth ratio of 2.11 and a beta of 0.69. The company has a 50 day moving average price of $92.42 and a 200 day moving average price of $87.57. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60.

Ventas (NYSE:VTR) last released its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to analyst estimates of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the prior year, the business earned $0.87 EPS. Equities research analysts predict that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Analysts Set New Price Targets

VTR has been the subject of several research reports. Scotiabank dropped their target price on shares of Ventas from $95.00 to $88.00 and set a “sector perform” rating for the company in a report on Thursday, June 18th. BMO Capital Markets upped their price target on Ventas from $105.00 to $107.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 11th. Jefferies Financial Group raised their price target on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $100.00 price objective on shares of Ventas in a research note on Tuesday, June 16th. Finally, UBS Group boosted their price objective on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $98.00.

Insider Activity at Ventas

In related news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the acquisition, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.53% of the stock is currently owned by company insiders.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.